alpha-D-galactosidase enzyme 450 UNT Disintegrating Oral Tablet [Beano]

RxNorm concept 2608084, branded drug (sbd). Prescribable name: Beano 450 UNT Disintegrating Oral Tablet.

RxCUI: 2608084
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2608084 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

alpha-D-galactosidase enzyme 259351

Other names

Beano 450 UNT Disintegrating Oral Tablet

Related concepts

alpha-D-galactosidase enzyme 450 UNT (SCDC, consists of)
alpha-D-galactosidase enzyme 450 UNT [Beano] (SBDC, consists of)
Disintegrating Oral Tablet (DF, has dose form)
Beano (BN, has ingredient)
alpha-D-galactosidase enzyme 450 UNT Disintegrating Oral Tablet (SCD, tradename of)

Linked data

NDCs

42037010692

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2608084 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2608084 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2608084. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.